Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,148.00    9.00 (0.79%)
Bid:
1,147.50
Ask:
1,148.00
Spread: 0.50 (0.044%)
Market Cap: £9.74b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

29 Aug 2025 10:57

RNS Number : 2505X
Smith & Nephew Plc
29 August 2025
 

SMITH & NEPHEW PLC

 

29 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

 

1. AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020

 

On 27 August 2025, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted to Ajay Dhankhar under the Smith & Nephew Global Share Plan 2020. The awards have been made in London and are based on the closing Share price on the London Stock Exchange between 6 and 19 August 2025 inclusive, of £13.48.

 

i. PERFORMANCE SHARE PROGRAMME 2025 AWARDS

 

The following Performance Share awards will vest as follows:

 

a. *40,005 shares will vest on 8 March 2027 subject to the achievement of performance conditions measured over the period 1 January 2024 to 31 December 2027; and

b. **87,370 shares will vest on 27 August 2028 subject to the achievement of performance conditions measured over the period 1 January 2025 to 31 December 2028.

 

\* The number of shares subject to the above awards are shown at target vesting. Should maximum vesting be achieved, the participant will receive 2x the number of shares shown above. The participant will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

 

** The number of shares subject to the above awards are shown at maximum vesting. This award will vest proportionally depending upon the extent to which the associated performance conditions are met. The participant will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

 

The following relates to the individual included in this section:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Performance Share awards granted at target under the

Smith & Nephew Global Share Plan 2020.

Date of Transaction

2025 - 08 - 27

Place of Transaction

Grant took place outside a trading venue

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Ajay Dhankhar (Chief Corporate Strategy & Development Officer)

PDMR

Nil

127,375

N/A Single Transaction

 

 

ii. SHARE AWARDS

 

One third of the share awards detailed below will vest on 27 August 2026, a further third will vest on 27 August 2027, and the final third will vest on 27 August 2028. Each vesting is subject to Ajay Dhankhar remaining in the employment of the Group on the vesting dates, not being under notice and not having achieved an "unsatisfactory performance" rating for his personal performance in the year prior to each vesting date.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Share awards granted under the Smith & Nephew Global Share Plan 2020.

Date of Transaction

2025 - 08 - 27

Place of Transaction

Grant took place outside a trading venue

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Ajay Dhankhar (Chief Corporate Strategy & Development Officer)

PDMR

Nil

82,572

N/A Single Transaction

 

 

 

2. AWARDS MADE UNDER THE RESTRICTED SHARE PLAN 2024

 

On 27 August 2025, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted to Ajay Dhankhar under the Smith & Nephew Restricted Share Plan 2024. The awards have been made in London and are based on the closing Share price on the London Stock Exchange between 6 and 19 August 2025 inclusive, of £13.48.

 

One third of the Restricted Share awards detailed below will vest on 27 August 2026, a further third will vest on 27 August 2027, and the final third will vest on 27 August 2028. Each vesting is subject to Ajay Dhankhar remaining in the employment of the Group on the vesting dates, not being under notice and not having achieved an "unsatisfactory performance" rating for his personal performance in the year prior to each vesting date.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Restricted Share awards granted under the Smith & Nephew Restricted Share Plan 2024

Date of Transaction

2025 - 08 - 27

Place of Transaction

Grant took place outside a trading venue

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Ajay Dhankhar (Chief Corporate Strategy & Development Officer)

PDMR

Nil

39,359

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFEATVIAFIE
Date   Source Headline
1st Aug 201911:45 amRNSBlock listing Interim Review
1st Aug 201911:18 amRNSTotal Voting Rights
31st Jul 20197:00 amRNSHalf-year Report
23rd Jul 20198:37 amRNSDirector/PDMR Shareholding
15th Jul 20194:00 pmRNSNotice of Results
1st Jul 201911:14 amRNSSmith & Nephew acquires Atracsys Sàrl
1st Jul 201910:44 amRNSTotal Voting Rights
28th Jun 201910:28 amRNSDirector/PDMR Shareholding
13th Jun 20192:12 pmRNSDirector/PDMR Shareholding
11th Jun 20197:00 amRNSSmith & Nephew to acquire Atracsys Sàrl
3rd Jun 20192:31 pmRNSTotal Voting Rights
3rd Jun 20197:00 amRNSCompletion of Brainlab OJR business acquisition
30th May 201910:03 amRNSAdditional Listing
23rd May 20192:41 pmRNSDirector/PDMR Shareholding
20th May 201911:03 amRNSDirector/PDMR Shareholding
16th May 201910:47 amRNSDirector/PDMR Shareholding
15th May 20193:00 pmRNSTransaction in Own Shares
14th May 20195:42 pmRNSTransaction in Own Shares
13th May 20196:04 pmRNSTransaction in Own Shares
13th May 20191:52 pmRNSDirector/PDMR Shareholding
10th May 20196:03 pmRNSTransaction in Own Shares
10th May 20193:35 pmRNSDirector/PDMR Shareholding
10th May 201910:21 amRNSDirector/PDMR Shareholding
9th May 20195:51 pmRNSTransaction in Own Shares
9th May 20193:14 pmRNSDirector/PDMR Shareholding
8th May 20195:29 pmRNSTransaction in Own Shares
7th May 20195:51 pmRNSTransaction in Own Shares
7th May 20191:07 pmRNSDirector/PDMR Shareholding
7th May 201910:00 amRNSChange of Registered Office
3rd May 201911:37 amRNSTransaction in Own Shares
3rd May 201910:11 amRNSDirector/PDMR Shareholding
2nd May 20197:00 amRNSTrading Statement
1st May 201910:59 amRNSTotal Voting Rights
24th Apr 20195:28 pmRNSDividend Declaration
17th Apr 20195:21 pmRNSAcquisition
17th Apr 20192:05 pmRNSAcquisition
15th Apr 20199:00 amRNSNotice of Results
11th Apr 20194:54 pmRNSResult of AGM
1st Apr 201911:27 amRNSTotal Voting Rights
1st Apr 20199:00 amRNSAcquisition of Leaf Healthcare, Inc.
25th Mar 20199:00 amRNSRe-presented Historical Quarterly Revenue Analysis
13th Mar 20197:00 amRNSMulti-asset digital surgery and robotic ecosystem
12th Mar 20191:00 pmRNSSmith & Nephew to acquire Osiris Therapeutics, Inc
8th Mar 20191:31 pmRNSDirector/PDMR Shareholding
8th Mar 20191:29 pmRNSDirector/PDMR Shareholding
8th Mar 20191:27 pmRNSDirector/PDMR Shareholding
4th Mar 20194:08 pmRNSAnnual Financial Report
4th Mar 20193:42 pmRNSAnnual Financial Report
1st Mar 201911:43 amRNSTotal Voting Rights
19th Feb 20193:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.